
The availability of a novel predictive biomarker in diabetes care could have benefits for patients, payers, and pharma.

The availability of a novel predictive biomarker in diabetes care could have benefits for patients, payers, and pharma.

Published: March 18th 2016 | Updated:

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
